Globus Medical, Inc. updated earnings guidance for the full year 2024. The company updated its guidance for full year 2024 revenue in the range of $2.460 billion to $2.485 billion. This updated guidance is an increase over the prior full year 2024 revenue guidance of $2.450 billion to $2.475 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.2 USD | -0.75% | +1.08% | +24.23% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.23% | 8.94B | |
-6.03% | 180B | |
+1.08% | 109B | |
-2.19% | 68.93B | |
-5.98% | 46.41B | |
+12.31% | 45.43B | |
+7.63% | 43.26B | |
+15.98% | 30.05B | |
+16.01% | 25.19B | |
-9.57% | 23.19B |
- Stock Market
- Equities
- GMED Stock
- News Globus Medical, Inc.
- Globus Medical, Inc. Updates Earnings Guidance for the Full Year 2024